Stock PLSE PULSE BIOSCIENCES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Pulse Biosciences, Inc.

Equities

PLSE

US74587B1017

Advanced Medical Equipment & Technology

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-05-09 EDT 		5-day change 1st Jan Change
6.95 USD +0.72% Intraday chart for Pulse Biosciences, Inc. -13.66% -43.22%
05-09 Pulse Biosciences, Inc. Announces First U.S. Procedure with the CellFX nsPFA Percutaneous Electrode System CI
05-07 Transcript : Pulse Biosciences, Inc., Q1 2024 Earnings Call, May 07, 2024

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 235.8 278.8 604.6 438.8 103.1 674.2
Enterprise Value (EV) 1 176.3 260.1 595.5 421.5 117.9 639
P/E ratio -5.21 x -5.92 x -11.1 x -6.51 x -1.61 x -13.9 x
Yield - - - - - -
Capitalization / Revenue - - - 309,477,645 x 147,317,306 x -
EV / Revenue - - - 297,232,229 x 168,485,877 x -
EV / EBITDA -4.81 x -5.56 x -12.2 x -6.81 x -2.08 x -15.1 x
EV / FCF -17.9 x -15.3 x -31.7 x -13.9 x -4.39 x -35.2 x
FCF Yield -5.58% -6.54% -3.15% -7.21% -22.8% -2.84%
Price to Book 3.56 x 9.09 x 26.6 x 12.3 x -45.9 x 15.2 x
Nbr of stocks (in thousands) 20,579 20,788 25,342 29,631 37,228 55,081
Reference price 2 11.46 13.41 23.86 14.81 2.770 12.24
Announcement Date 19-03-14 20-03-16 21-03-12 22-03-31 23-03-31 24-03-28
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales - - - 1.418 0.7 -
EBITDA 1 -36.65 -46.79 -48.87 -61.87 -56.7 -42.37
EBIT 1 -37.96 -47.95 -49.96 -63.01 -58.06 -43.57
Operating Margin - - - -4,443.86% -8,293.86% -
Earnings before Tax (EBT) 1 -37.54 -46.97 -49.85 -63.66 -58.5 -42.21
Net income 1 -37.54 -46.97 -49.85 -63.66 -58.5 -42.21
Net margin - - - -4,489.42% -8,357.86% -
EPS 2 -2.198 -2.264 -2.144 -2.276 -1.724 -0.8787
Free Cash Flow 1 -9.827 -17.01 -18.77 -30.4 -26.84 -18.13
FCF margin - - - -2,143.67% -3,833.73% -
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 19-03-14 20-03-16 21-03-12 22-03-31 23-03-31 24-03-28
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2
Net sales 1 0.574 0.844 0.444 0.265 - -0.009 - -
EBITDA - - - - - - - -
EBIT 1 -14.27 -15.41 -17.27 -14.01 -18.02 -8.745 -9.562 -10.23
Operating Margin -2,486.59% -1,825.83% -3,890.32% -5,288.3% - 97,166.67% - -
Earnings before Tax (EBT) 1 -14.28 -15.42 -17.27 -14 -18.04 -9.197 -9.801 -9.91
Net income 1 -14.28 -15.42 -17.27 -14 -18.04 -9.197 -9.801 -9.91
Net margin -2,488.15% -1,826.54% -3,890.32% -5,281.51% - 102,188.89% - -
EPS 2 -0.4800 -0.5200 -0.5800 -0.4400 -0.4900 -0.2500 -0.2600 -0.2200
Dividend per Share - - - - - - - -
Announcement Date 21-11-15 22-03-31 22-05-11 22-08-10 22-11-10 23-03-30 23-05-11 23-08-10
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - 14.8 -
Net Cash position 1 59.6 18.7 9.12 17.4 - 35.2
Leverage (Debt/EBITDA) - - - - -0.2613 x -
Free Cash Flow 1 -9.83 -17 -18.8 -30.4 -26.8 -18.1
ROE (net income / shareholders' equity) -66.8% -96.8% -186% -217% -350% -200%
ROA (Net income/ Total Assets) -39.4% -53.3% -75.1% -82.4% -54.9% -39.7%
Assets 1 95.31 88.2 66.41 77.22 106.5 106.2
Book Value Per Share 2 3.220 1.480 0.9000 1.200 -0.0600 0.8000
Cash Flow per Share 2 2.480 0.3300 0.4900 0.9600 1.640 0.8000
Capex 1 0.28 0.61 0.44 0.44 0.4 0.12
Capex / Sales - - - 30.82% 57.29% -
Announcement Date 19-03-14 20-03-16 21-03-12 22-03-31 23-03-31 24-03-28
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

1st Jan change Capi.
PULSE BIOSCIENCES, INC. Stock Pulse Biosciences, Inc.
-43.22% 381M
THERMO FISHER SCIENTIFIC Stock Thermo Fisher Scientific
+8.88% 219B
DANAHER CORPORATION Stock Danaher Corporation
+8.68% 185B
INTUITIVE SURGICAL, INC. Stock Intuitive Surgical, Inc.
+14.25% 135B
BOSTON SCIENTIFIC CORPORATION Stock Boston Scientific Corporation
+28.18% 107B
EDWARDS LIFESCIENCES CORPORATION Stock Edwards Lifesciences Corporation
+14.65% 51.28B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. Stock Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
+4.48% 51.01B
AGILENT TECHNOLOGIES, INC. Stock Agilent Technologies, Inc.
+4.39% 41.85B
GE HEALTHCARE TECHNOLOGIES INC. Stock GE HealthCare Technologies Inc.
+7.00% 37.02B
RESMED, INC. Stock ResMed, Inc.
+26.06% 31.27B
Other Advanced Medical Equipment & Technology
  1. Stock Market
  2. Equities
  3. PLSE Stock
  4. Financials Pulse Biosciences, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW